✦ LIBER ✦

Nonmyeloablative stem cell transplantation following a cytoreductive autograft in patients with non-Hodgkin's lymphoma who relapse after autologous transplantation

✍ Scribed by Yang, D-H; Lee, J-J; Kim, Y-K; Cho, S-H; Chung, I-J; Kim, H-J

Book ID: 110014328
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 72 KB
Volume: 34
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704668

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allogeneic stem cell transplantation in

Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation

✍ Ji-Won Kim; Byung-Su Kim; Soo-Mee Bang; Inho Kim; Dong Hwan Kim; Won Seog Kim; D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB

Autologous hematopoietic stem cell trans

Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphoma

✍ Buadi, F K; Micallef, I N; Ansell, S M; Porrata, L F; Dispenzieri, A; Elliot, M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Therapeutic options for patients with ho

Therapeutic options for patients with hodgkin’s disease and non-hodgkin’s lymphoma who relapse after autologous transplant

✍ Koen van Besien; Sonali Smith; Hillard M. Lazarus 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 284 KB

Interferon-α after autologous stem cell

Interferon-α after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma

✍ Petropoulos, D; Worth, L L; Mullen, C A; Lockhart, S; Choroszy, M; Chan, K W 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Rituximab long-term maintenance therapy

Rituximab long-term maintenance therapy after autologous stem cell transplantation in patients with B-cell non-Hodgkin’s lymphoma

✍ Frank Neumann; Stefani Harmsen; Simona Martin; Ralf Kronenwett; Mustafa Kondakci 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 96 KB

Therapeutic results in patients with rel

Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation

✍ Felicetto Ferrara; Assunta Viola; Carolina Copia; Ettore Mariano Schiavone; Mari 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

## Abstract Forty patients with relapsed diffuse large B cell lymphoma (DLBCL) autografted in partial response (PR) (__n__ = 23) or in refractory relapse (RR) (__n__ = 17) achieved complete remission (CR) after autologous stem cell transplantation (ASCT). Salvage treatment consisted of ifosphamide,